ARA-290
An EPO-derived innate repair receptor agonist studied for neuropathic pain and tissue protection without stimulating red blood cell production.
Research status: Clinical trials in neuropathic pain populations.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Related in Healing